@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.eu/fhir/ig/gravitate-health/Composition/cfsb1639016804189> a fhir:Composition;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "cfsb1639016804189"];
  fhir:Resource.language [ fhir:value "en"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb1639016804189\"  (Language \"en\") </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>date</b>: 2015-02-07T13:28:17Z</p><p><b>author</b>: <a href=\"Organization-cfsb1639003145277.html\">Organization/cfsb1639003145277</a> \"Almirall S.A.\"</p><p><b>title</b>: TEST PURPOSES ONLY - skilarence Vulcan ePI</p><p><b>confidentiality</b>: unrestricted</p></div>"
  ];
  fhir:Composition.status [ fhir:value "final"];
  fhir:Composition.type [
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/" ];
       fhir:Coding.code [ fhir:value "100000155538" ]
     ];
     fhir:CodeableConcept.text [ fhir:value "Package Leaflet" ]
  ];
  fhir:Composition.date [ fhir:value "2015-02-07T13:28:17Z"^^xsd:dateTime];
  fhir:Composition.author [
     fhir:index 0;
     fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/cfsb1639003145277>;
     fhir:Reference.reference [ fhir:value "Organization/cfsb1639003145277" ]
  ];
  fhir:Composition.title [ fhir:value "TEST PURPOSES ONLY - skilarence Vulcan ePI"];
  fhir:Composition.confidentiality [ fhir:value "unrestricted"];
  fhir:Composition.section [
     fhir:index 0;
     fhir:Composition.section.title [ fhir:value "6. Contents of the pack and other information" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/" ];
         fhir:Coding.code [ fhir:value "100000155538-6" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "B. PACKAGE LEAFLET" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>What Skilarence 30 mg contains</b></p><ul><li>the active substance is dimethyl fumarate. One tablet contains 30 mg dimethyl fumarate.</li><li>the other ingredients are: lactose monohydrate, cellulose microcrystalline, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, methacrylic acid-ethyl acrylate copolymer (1:1), talc, triethyl citrate, titanium dioxide (E171) and simethicone.</li></ul><p><b>What Skilarence 30 mg looks like and contents of the pack</b></p><p>Skilarence 30 mg is a white, round tablet with a diameter of approximately 6.8 mm. Skilarence 30 mg is available in packs containing 42, 70 and 210 gastro-resistant tablets. Not all pack sizes may be marketed. The tablets are packed in PVC/PVDC-aluminium blisters.</p><p><b>Marketing Authorisation Holder and Manufacturer</b></p><p><b>Marketing Authorisation Holder</b></p><p>Almirall, S.A.</p><p>Ronda General Mitre, 151 E-08022 Barcelona</p><p>Spain</p><p>Tel. +34 93 291 30 00</p><p><b>Manufacturer</b></p><p>Industrias Farmacéuticas Almirall, S.A. Ctra. de Martorell 41-61</p><p>E-08740 Sant Andreu de la Barca, Barcelona Spain</p><p>For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</p><p><b>België/Belgique/Belgien/ Luxembourg/Luxemburg</b></p><p>Almirall N.V., Tél/Tel: +32 (0)2 771 86 37</p><p><b>България/ Česká republika/ Eesti/ España/ Hrvatska/ Κύπρος/ Latvija/ Lietuva/ Magyarország/ Malta/ România/ Slovenija/ Slovenská republika</b></p><p>Almirall, S.A., Teл./ Tel/ Τηλ: +34 93 291 30 00</p><p>Tel (Česká republika / Slovenská republika): +420 220 990 139</p><p><b>Danmark/ Norge/ Suomi/Finland/ Sverige Almirall ApS, Tlf/ Puh/Tel: +45 70 25 75 75</b></p><p><b>Deutschland</b></p><p>Almirall Hermal GmbH, Tel.: +49 (0)40 72704-0</p><p><b>Ελλάδα</b></p><p>Galenica A.E., Tηλ: +30 210 52 81 700</p><p><b>France</b></p><p>Almirall SAS, Tél.: +33(0)1 46 46 19 20</p><p><b>Ireland/ United Kingdom (Northern Ireland)</b></p><p>Almirall, S.A., Tel: +353 (0) 1431 9836</p><p><b>Ísland</b></p><p>Vistor hf., Sími: +354 535 70 00</p><p><b>Italia</b></p><p>Almirall SpA, Tel.: +39 02 346181</p><p><b>Nederland</b></p><p>Almirall B.V., Tel: +31 (0)30 799 1155</p><p><b>Österreich</b></p><p>Almirall GmbH, Tel.: +43 (0)1/595 39 60</p><p><b>Polska</b></p><p>Almirall Sp.z o. o., Tel.: +48 22 330 02 57</p><p><b>Portugal</b></p><p>Almirall - Produtos Farmacêuticos, Lda., Tel.: +351 21 415 57 50</p><p>This leaflet was last revised in .</p><p><b>Other sources of information</b></p><p>Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.</p></div>"
     ]
  ] .

# - ontology header ------------------------------------------------------------

<http://hl7.eu/fhir/ig/gravitate-health/Composition/cfsb1639016804189.ttl> a owl:Ontology;
  owl:imports fhir:fhir.ttl .

# -------------------------------------------------------------------------------------

